Oncology startup Segasist prepares to unveil 'revolutionary' technology, has grown from... - 0 views
-
Assunta Krehl on 28 Sep 11The week of October 3, 2011, Segasist Technologies, a MaRS client and tenant will launch its' new cancer diagnostic tool Reconcillio at the American Society for Radiation Oncology conference. Reconcillio is Segasist Technologies' third product and is awaiting FDA approvals.